Arch Therapeutics, Inc. is a biotechnology company based in Henderson, NV, specializing in the development of innovative medical devices to address bleeding, wound management, and leakage control during surgical procedures and trauma care. Their self-assembling barrier technology platform aims to provide faster and safer patient care, with products such as the AC5 Advanced Wound System and AC5 Topical Hemostat already authorized for medical use in the United States and Europe.
With a focus on hemostasis and wound management, Arch Therapeutics is dedicated to advancing the field of healthcare through their investigational devices, including AC5-G, AC5-V, and AC5 Surgical Hemostat. Their goal is to revolutionize surgical and interventional care by providing effective solutions for bleeding control and wound management.
Generated from the website